Advancing Immuno

Experience groundbreaking in-person events, engaging online activities, and cutting-edge digital services that unite influential and passionate leaders with scientific experts, collectively shaping the future of immunotherapy.

In-Person & Online Events

Collaborate & Partner for a Better Future

Explore Immuno

Unite with the immuno industry's foremost leaders and scientific experts through our year-round activities. Immerse yourself in cutting-edge scientific content that sparks thought-provoking insights, providing a unique perspective on the latest R&D trends and challenges.

Resources & Announcements

23/04/24 - The NK cell therapy is being trialled in combination with monoclonal antibody therapy and hopes to induce B-cell depletion.
09/04/24 - The small exploratory trial shows signs that iNKT cells can improve the survival rate of respiratory distress from COVID-19.
20/03/24 - Oncolytic virotherapy targets cancer cells with viruses, promising personalized treatment with minimal side effects. Safety measures include minimizing off-target effects and systemic spread. Combining with immunotherapy enhances efficacy, revolutionizing cancer treatment.
19/03/24 - More results are in for the oncolytic potential of the Zika virus, where it has proven effective against the most common form of brain cancer in vitro.
06/03/24 - One of the deadliest cancers in children could have its survival rate improved by the advent of new research into the oncolytic effect of Zika virus.
29/02/24 - The team aims to establish a consortium of cancer centres to join the project of developing biomarkers from multi-omic analysis.

Online Activities

03/06/24 | Science Exchange

Target Identification for ADCs

13/06/24 | Science Exchange

Immunogenicity Considerations for Biologics Development

01/11/24 | Science Exchange

Immunotherapies For Solid Tumour Targeting

Oxford Global PLUS Pass

Introducing the PLUS Pass – your exclusive 12-month, all-access gateway to over 40 prestigious events hosted annually across the UK, Europe, and the US.

Tailored for experts, thought-leaders, and scientists from global pharma & biotech, the PLUS Pass not only grants you entry to our curated event experiences but also offers boundless knowledge sharing through our robust PLUS Platform. Immerse yourself in a wealth of on-demand event recordings, content articles, and industry news, while engaging in thought-provoking exclusive webinars and stimulating group discussions each month.

Oxford Global PLUS


Driving impact, awareness, and business generation

Our extensive and engaged community extends across large, mid-size and innovative start-ups within the pharma and biotech space, with a dedicated audience spanning a range of specialisms. Whether you have content to share, are looking for ways to enhance your brand visibility or would like to increase engagement with prospective customers, Oxford Global can offer valuable access to your target demographic through our range of event & content services.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things immuno